 | |
| Company type | KGaA with Aktiengesellschaft as partner with unlimited liability |
|---|---|
| FWB: 1SXP | |
| ISIN | DE000A3ENQ51 |
| Industry | Healthcare |
| Founded | August 1, 2022 |
| Headquarters | Mainz, Germany |
Key people | Andreas Reisse, CEO Almuth Steinkühler, CFO |
| Products | Pharmaceutical drug containment and delivery systems |
| Revenue | €899 million (2022/2023)[1] |
| Owner | Schott AG |
Number of employees | 4,646 (as of September 30, 2023)[1] |
| Divisions |
|
| Website | schott-pharma |
Schott Pharma (stylized as SCHOTT Pharma) is a provider of drug containment solutions and delivery systems for injectable drugs.[2][3] Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023.[4] Headquartered in Mainz, Germany,[5][6] the company operates in 14 countries.[7]
- ^ a b SCHOTT Pharma Annual Report 2022/2023 (accessed February 08, 2024)
- ^ Kansteiner, Fraiser (2023-12-23). "Glass specialist Schott Pharma touts 2023 sales growth, Serbia expansion and hiring plans". Fierce Pharma. Retrieved 2024-04-08.
- ^ "EQS-News: SCHOTT Pharma bestätigt Prognose für das Geschäftsjahr 2024 anlässlich seiner Q2-Ergebnisse; Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst" [EQS-News: SCHOTT Pharma confirms forecast for the 2024 financial year on the occasion of its Q2 results; financial year 2025 influenced by lower growth in syringes]. 4Investors.de (in German). 2024-05-14. Retrieved 2024-06-24.
- ^ Rauffmann, Theresa (2024-06-27). "Abhängigkeit vom Geschäft mit Diätspritzen wird zum Problem" [Dependence on the business with diet syringes becomes a problem]. www.handelsblatt.com. Retrieved 2024-09-18.
- ^ Ibrahim, Samir (2023-09-28). "Schott Pharma startet erfolgreich an der Frankfurter Börse". tagesschau.de (in German). Retrieved 2024-06-24.
- ^ Nünchert, Ike (2022-08-03). "SCHOTT Pharma: Carve-Out für ein mögliches IPO" [SCHOTT Pharma: Carve-Out for a possible IPO]. Going Public. Retrieved 2024-06-24.
- ^ "Größter Börsengang in 2023: So hat sich die SCHOTT Pharma-Aktie seit ihrem IPO entwickelt - und so könnte es in 2024 nun weitergehen". finanzen.net. 2024-01-24. Retrieved 2024-02-28.